These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3624772)

  • 1. Comparison of effects of ozone, cadmium chloride and carbon tetrachloride on [14C]antipyrine metabolism in conscious rats.
    Dutta S; Kamat M; Gole D
    J Appl Toxicol; 1987 Apr; 7(2):97-103. PubMed ID: 3624772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of ozone-induced edema in the isolated rat lung in relation to arachidonic acid metabolism, mixed-function oxidases and angiotensin converting enzyme activities.
    Dutta S; Chatterjee M; Teknos TN; Carlson RW
    Pulm Pharmacol; 1990; 3(2):65-72. PubMed ID: 1966904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antipyrine metabolite formation in rats in vivo.
    Rhodes JC; Hall ST; Houston JB
    Xenobiotica; 1984 Sep; 14(9):677-86. PubMed ID: 6516440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pregnenolone carbonitrile, promethazine and antipyrine pretreatment on antipyrine metabolite formation in rats.
    Shaw PN; Hall ST; Houston JB
    Xenobiotica; 1986 Dec; 16(12):1109-16. PubMed ID: 3798958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipyrine metabolite kinetics in rats: studies on dose and time dependence.
    Rhodes JC; Houston JB
    Biopharm Drug Dispos; 1983; 4(2):125-35. PubMed ID: 6411138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antipyrine breath test in the rat: a pharmacokinetic model.
    Lockwood GF; Chenery RJ; Oldham HG; Standring P; Norman SJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):207-14. PubMed ID: 3149242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs.
    Slørdal L; Høyem-Johansen T; Aarbakke J
    Pharmacology; 1983; 26(2):95-9. PubMed ID: 6844394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat lung metabolism after 3 days of continuous exposure to 0.6 ppm ozone.
    Bassett DJ; Bowen-Kelly E
    Am J Physiol; 1986 Feb; 250(2 Pt 1):E131-6. PubMed ID: 3953786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
    Buters JT; Zysset T; Reichen J
    Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of moderate fluosol-DA hemodilution on gender specific metabolism of antipyrine.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):455-62. PubMed ID: 2781142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of xylene exposure on the metabolism of antipyrine in vitro and in vivo in the rat.
    Toftgård R
    Toxicology; 1983 Sep; 28(1-2):117-31. PubMed ID: 6636196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal effects on antipyrine metabolite kinetics in Aroclor 1254-treated rats.
    Shaw PN; Houston JB
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):232-40. PubMed ID: 3087023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon reduces hepatic drug metabolism in vivo in mice.
    Taylor G; Marafino BJ; Moore JA; Gurley V; Blaschke TF
    Drug Metab Dispos; 1985; 13(4):459-63. PubMed ID: 2863111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 14C-antipyrine in suspensions of isolated rat liver cells.
    Aarbakke J; Bessesen A; Morland J
    Acta Pharmacol Toxicol (Copenh); 1977 Sep; 41(3):225-34. PubMed ID: 578651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinetic evaluation of 14CO2 in expired air after 14C-methacetin administration in rats, used for the in vivo study of the metabolism of drugs.
    Thornhill DP; Steffen C; Netter KJ
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):161-8. PubMed ID: 6430705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the pharmacokinetics of carbon tetrachloride in the rat following repeated inhalation exposures of 8 and 11.5 hr/day.
    Paustenbach DJ; Carlson GP; Christian JE; Born GS
    Fundam Appl Toxicol; 1986 Apr; 6(3):484-97. PubMed ID: 3084329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats.
    Shaw PN; Tseti J; Warburton S; Adedoyin A; Houston JB
    Drug Metab Dispos; 1986; 14(2):271-6. PubMed ID: 2870906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.
    Uchino H; Inaba T; Kalow W
    Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of sodium chromate and carbon tetrachloride on the urinary excretion and tissue distribution of cadmium in cadmium-pretreated rats.
    Bernard AM; Lauwerys RR
    Toxicol Appl Pharmacol; 1981 Jan; 57(1):30-8. PubMed ID: 7209985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.